Related Experiment Videos
A new class of ribozyme from hepatitis B virus
Chun Shen Lim1, Christopher Brown1
1Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
The FEBS Journal
|April 18, 2017
Summary
A hepatitis B virus (HBV) region acts as a novel ribozyme. This self-cleaving RNA molecule then functions in trans, degrading other RNA targets, revealing unique catalytic properties.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- The hepatitis B virus (HBV) epsilon region is crucial for viral replication.
- Ribozymes are RNA molecules with catalytic activity, capable of self-cleavage or acting on other nucleic acids.
Purpose of the Study:
- To investigate the catalytic properties of a specific 53-base region of the HBV epsilon region.
- To characterize the self-cleavage mechanism and identify the resulting catalytic species.
Main Methods:
- In vitro analysis of the HBV epsilon region.
- Identification of self-cleavage sites and characterization of the released RNA species.
Main Results:
- A 53-base fragment of the HBV epsilon region demonstrated ribozyme activity.
- Self-cleavage occurred at the UAUAAA polyadenylation signal and the epsilon region's 'centre bulge'.
- The released ribozyme exhibited trans-cleavage activity on other RNA molecules, representing a new class.
Conclusions:
- The studied HBV epsilon region fragment possesses unusual ribozyme properties.
- This ribozyme can act in trans, suggesting a novel mechanism for RNA processing or regulation in HBV.